STAT - Reporting from the frontiers of health and medicine

Skip to Main Content

Explore what it takes to make the health care system work.

Explore what it takes to make the health care system work.

December 18, 2023

STAT Virtual Event | Cancer’s Breakthrough Engine
December 18, 2023

Biden administration asks judge to toss out Humana’s Medicare Advantage audit lawsuit
December 18, 2023

Apple pauses sales of latest watches in the U.S. after ITC decision
December 18, 2023

Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal
December 18, 2023

The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive
December 18, 2023

Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility

Report cover: STAT’s bestselling guide to interpreting clinical trials 2023 update

Now updated: STAT’s bestselling guide to interpreting clinical trials

Download the report

STAT Plus: ‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA

Stealth BioTherapeutics, which is developing a therapy for Barth syndrome, has had an especially trying time seeking FDA approval.

Health December 18, 2023

STAT Plus: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds

Health Tech December 18, 2023

STAT Plus: New Jersey’s telehealth restrictions cut off access to lifesaving care, lawsuit alleges

Biotech December 18, 2023

STAT Plus: Here are the best biopharma CEOs of 2023

Business December 17, 2023

STAT Plus: The biggest health care deals of 2023

Sponsored

Advertisement

All First Opinion

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA

Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

Here are the best biopharma CEOs of 2023

Humana used algorithm in ‘fraudulent scheme’ to deny care to Medicare Advantage patients, lawsuit alleges

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2024 STAT Breakthrough Summit East

New York, NY March 21, 2024

At 2024 Breakthrough Summit East, we gather industry leaders & patients to find real answers on how to make sure that science is benefiting the ones who desperately need it.

19

Dec

Cancer’s Breakthrough Engine

Virtual

08

Jan

STAT@JPM: Co-Working Space

San Francisco, CA

09

Jan

STAT@JPM: What’s Next in Biotech?

San Francisco, CA

All Events

More Stories

Health December 18, 2023

STAT Virtual Event | Cancer’s Breakthrough Engine

Insurance December 18, 2023

STAT Plus: Biden administration asks judge to toss out Humana’s Medicare Advantage audit lawsuit

Health Tech December 18, 2023

STAT Plus: Apple pauses sales of latest watches in the U.S. after ITC decision

Biotech December 18, 2023

STAT Plus: Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal

The Readout December 18, 2023

The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive

Pharmalot December 18, 2023

STAT Plus: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility

Biotech December 18, 2023

STAT Plus: Structure Therapeutics GLP-1 pill cuts blood sugar, weight in early diabetes study

First Opinion December 18, 2023

Alzheimer’s drug approvals show we need a reevaluation of patient advocacy

Matt's Take December 17, 2023

STAT Plus: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

Letters to the editor December 16, 2023

STAT readers on teaching medical students about intellectual disabilities, sobering centers, and annual wellness visits

First Opinion December 16, 2023

The WHO recognizes noma after years of medical-dental disconnect

In the Lab December 15, 2023

NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry

Pharmalot December 15, 2023

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout December 15, 2023

STAT Plus: FDA chastens pet companies over antibiotics

Pharmalot December 15, 2023

STAT Plus: Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish

Biotech December 15, 2023

STAT Plus: European regulators endorse Casgevy, paving way for approval of CRISPR-based therapy

Politics December 14, 2023

STAT Plus: Sanders blames food companies for diabetes epidemic

Pharmalot December 14, 2023

STAT Plus: In response to criticism, FDA publishes new database of wayward clinical trial sponsors

Matt's Take December 17, 2023

STAT Plus: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

Letters to the editor December 16, 2023

STAT readers on teaching medical students about intellectual disabilities, sobering centers, and annual wellness visits

First Opinion December 15, 2023

The federal government fails to provide Americans with reproductive health information they need. Here’s a better approach

First Opinion December 14, 2023

Europe’s lessons for the U.S. on how to cover weight loss drugs

First Opinion December 14, 2023

In mifepristone case, the Supreme Court must affirm the FDA’s authority. Medical innovation is at risk

First Opinion December 13, 2023

Exceptions to abortion restrictions often fail people like Kate Cox whose babies are sure to die

Newsletters

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

New gene therapies confront many sickle cell patients with an impossible choice: a cure or fertility

By Megan Molteni

Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure

By Helen Branswell

Mexico’s activist ‘companion networks’ quietly provide abortion pills and support to U.S. women

By Olivia Goldhill

New England Journal of Medicine reckons with its racist past and complicity in slavery

By Usha Lee McFarling

STAT Plus: How sickle cell became the first disease treated by CRISPR

STAT Plus: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices

By Ed Silverman

STAT Plus: Proposal to protect abortion patients’ records faces pushback from Epic, UnitedHealth

By Paul Webster

How the Bad River Tribe flipped the script on the Native American opioid crisis

STAT Plus: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

Biotech December 14, 2023

STAT Plus: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

Biotech December 13, 2023

STAT Plus: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in

Biotech December 13, 2023

STAT Plus: Vertex non-opioid drug reduces chronic nerve pain in mid-stage study

STAT Plus: Why FDA product recalls have spiked in recent years

Pharma December 14, 2023

STAT Plus: Why FDA product recalls have spiked in recent years

Pharmalot December 14, 2023

STAT Plus: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access

Pharmalot December 13, 2023

STAT Plus: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial

Kate Cox is one of hundreds in Texas denied abortions despite serious health risks, data show

Health December 15, 2023

Kate Cox is one of hundreds in Texas denied abortions despite serious health risks, data show

Health December 14, 2023

When Dobbs forced one doctor to shutter his abortion clinic, he took his mission on the road

Health December 13, 2023

Doctors call out ableism in cancer care: ‘The biggest accommodation is attitude’

STAT Plus: Supreme Court will decide abortion pill access

Politics December 13, 2023

STAT Plus: Supreme Court will decide abortion pill access

Politics December 11, 2023

STAT Plus: House passes site-neutral policy, transparency, PBM reform package

Politics December 11, 2023

STAT Plus: UnitedHealth executive to head health insurance group AHIP

Video

Treating Rural America: The telehealth solution

A conversation with the 2023 STAT Wunderkinds

Treating Rural America: The new country doctors

Treating Rural America: The last doctor in town

biotech

biotech

STAT Plus: Amputees have better balance, less pain after electrical stimulation, study finds

Health Tech December 14, 2023

STAT Plus: Amputees have better balance, less pain after electrical stimulation, study finds

Health Tech December 14, 2023

STAT Plus: Health records don’t always show when patients are dead. One researcher is trying to change that

Health Tech December 13, 2023

STAT Plus: Bankrupt Pear’s addiction treatments acquired by virtual care company

STAT Plus: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study

In the Lab December 9, 2023

STAT Plus: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study

In the Lab December 8, 2023

STAT Plus: New proposals for scientific misconduct investigations worry some research universities

In the Lab December 6, 2023

‘Last roll of the dice’ for a near-term HIV vaccine fails

North Carolina attorney general sues HCA for lapses at Mission Health

Hospitals December 14, 2023

North Carolina attorney general sues HCA for lapses at Mission Health

Hospitals December 5, 2023

STAT Plus: Senate panel considers Medicare policy fixes to drug shortages

Hospitals November 24, 2023

STAT Plus: Antitrust lawsuit alleges UnitedHealth’s Optum pressured a California hospital to stop competing over physicians

STAT Plus: Hot antitrust environment hangs over called-off merger between Cigna and Humana

Insurance December 11, 2023

STAT Plus: Hot antitrust environment hangs over called-off merger between Cigna and Humana

Insurance December 8, 2023

Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials

Insurance December 6, 2023

STAT Plus: Stephen Hemsley, UnitedHealth Group board chair, sells nearly $113 million in stock

Podcasts

FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future

When do tests hurt more than help?

CRISPR history, biotech struggles, & a big week for deals

Rep. Raul Ruiz on going from the emergency room to Congress